Perioperative Treatment of High-risk Resectable CCA With HAIC Plus A+T: Neobrave CCA

NCT06739252 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Difficulty of participants enrollment

Conditions

Intrahepatic Cholangiocarcinoma (Icc)
Perihilar Cholangiocarcinoma

Interventions

COMBINATION_PRODUCT: Gemcitabine Oxaliplatin and 5FU

Sponsor

Peking University